Skip to main content
Top
Published in: International Urology and Nephrology 3/2001

01-09-2001

CD44 standard form expression as a predictor of progression in high risk superficial bladder tumors

Authors: Nickolaos E. Stavropoulos, Ioannis Filliadis, Elli Ioachim, Michael Michael, Efpraxia Mermiga, Konstantinos Hastazeris, Unyime O. Nseyo

Published in: International Urology and Nephrology | Issue 3/2001

Login to get access
Metadata
Title
CD44 standard form expression as a predictor of progression in high risk superficial bladder tumors
Authors
Nickolaos E. Stavropoulos
Ioannis Filliadis
Elli Ioachim
Michael Michael
Efpraxia Mermiga
Konstantinos Hastazeris
Unyime O. Nseyo
Publication date
01-09-2001
Publisher
Kluwer Academic Publishers
Published in
International Urology and Nephrology / Issue 3/2001
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1023/A:1019589923706

Other articles of this Issue 3/2001

International Urology and Nephrology 3/2001 Go to the issue

Instructions for Authors

Instructions for authors

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine